Načítá se...

Adenoviral Pneumonia During Etanercept Treatment in a Patient with Rheumatoid Arthritis

Inhibitors of tumor necrosis factor-alpha (TNF-α) have been approved for treating rheumatoid arthritis. As one of the biological response modifiers, etanercept has also been used in the treatment of psoriatic arthritis and inflammatory bowel disease. While etanercept is effective, certain infectious...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Kang, Min-Jung, Kim, Myung-Sin, Choi, Eun-Hwa, Lee, Kyoung-Eun, Kim, You-Kyoung, Choi, Hee-Jung
Médium: Artigo
Jazyk:Inglês
Vydáno: The Korean Association of Internal Medicine 2007
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2687603/
https://ncbi.nlm.nih.gov/pubmed/17427651
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3904/kjim.2007.22.1.63
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!